Linked e-resources

Details

Session 1
Risk stratification and prognosis
Session 2
Screening and surveillance: invasive and noninvasive methods
Session 3
Changing scenarios I: Impact of etiological therapy for cirrhosis and of anti-fibrotic therapy on portal hypertension
Session 4
The gut microbiome and cirrhosis
Session 5
Changing scenarios II: What to do after successful cure of the etiologic factor?
Session 6
Management of the acute bleeding episode
Session 7
Controversies and challenges in Pediatrics
Session 8
Prevention of further decompensation (ascites, spontaneous bacterial peritonitis, hepatorenal syndrome, hepatic encephalopathy)
Session 9 Vascular diseases of the liver in cirrhotic and non-cirrhotic portal hypertension: coagulation, anti-coagulation, anti-platelet drugs.

Browse Subjects

Show more subjects...

Statistics

from
to
Export